CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 59 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $526,283 | -32.8% | 360,380 | +5.3% | 0.00% | – |
| Q2 2023 | $783,360 | +189.1% | 342,079 | +14.9% | 0.00% | – |
| Q1 2023 | $270,998 | +107013.8% | 297,800 | 0.0% | 0.00% | – |
| Q4 2022 | $253 | -99.9% | 297,800 | -0.2% | 0.00% | – |
| Q3 2022 | $244,000 | -17.3% | 298,460 | 0.0% | 0.00% | – |
| Q2 2022 | $295,000 | -39.7% | 298,460 | 0.0% | 0.00% | – |
| Q1 2022 | $489,000 | -28.7% | 298,460 | +4.8% | 0.00% | – |
| Q4 2021 | $686,000 | -32.5% | 284,874 | +35.5% | 0.00% | – |
| Q3 2021 | $1,017,000 | +101.0% | 210,243 | +10.9% | 0.00% | – |
| Q2 2021 | $506,000 | +10.5% | 189,541 | +27.4% | 0.00% | – |
| Q1 2021 | $458,000 | +16.5% | 148,834 | +34.5% | 0.00% | – |
| Q4 2020 | $393,000 | -12.1% | 110,660 | -0.8% | 0.00% | – |
| Q3 2020 | $447,000 | +14.0% | 111,548 | -22.7% | 0.00% | – |
| Q2 2020 | $392,000 | +33.8% | 144,362 | +3.9% | 0.00% | – |
| Q1 2020 | $293,000 | -80.4% | 138,916 | -49.5% | 0.00% | – |
| Q4 2019 | $1,496,000 | +284.6% | 275,110 | +112.7% | 0.00% | – |
| Q3 2019 | $389,000 | -9.3% | 129,357 | +12.7% | 0.00% | – |
| Q2 2019 | $429,000 | -34.4% | 114,794 | -29.5% | 0.00% | – |
| Q1 2019 | $654,000 | -41.5% | 162,891 | -46.5% | 0.00% | – |
| Q4 2018 | $1,118,000 | +1.8% | 304,722 | +138.0% | 0.00% | – |
| Q3 2018 | $1,098,000 | -18.9% | 128,039 | +3.8% | 0.00% | – |
| Q2 2018 | $1,354,000 | +54.7% | 123,353 | +62.4% | 0.00% | – |
| Q1 2018 | $875,000 | +14.2% | 75,962 | +2.7% | 0.00% | – |
| Q4 2017 | $766,000 | -34.5% | 73,999 | +0.9% | 0.00% | – |
| Q3 2017 | $1,169,000 | +40.5% | 73,373 | +6.7% | 0.00% | – |
| Q2 2017 | $832,000 | -1.2% | 68,774 | +69.6% | 0.00% | – |
| Q1 2017 | $842,000 | +55.1% | 40,550 | +6.8% | 0.00% | – |
| Q4 2016 | $543,000 | -10.4% | 37,980 | +3.0% | 0.00% | – |
| Q3 2016 | $606,000 | – | 36,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |